PIKfyve-IN-2
Product Specifications
UNSPSC Description
PIKfyve-IN-2 is a potent PIKfyve kinase inhibitor and can be used for cancers, autoimmune disorders research[1].
Target Antigen
PIKfyve
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pikfyve-in-2.html
Solubility
DMSO : 1.67 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
CC1=CC=CC(/C=N/NC2=NC3=NC(C4=CC=NC=C4)=NN3C(N5CCOCC5)=C2)=C1
Molecular Weight
414.46
References & Citations
[1]Sergei Romanov, et al. Fused triazolo-pyrimidine compounds having useful pharmaceutical application. Patent WO2018175906A1.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-154956/PIKfyve-IN-2-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-154956/PIKfyve-IN-2-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2245319-25-7
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
BAMBI (BMP and Activin Membrane-bound Inhibitor Homolog, Non-metastatic Gene A Protein, NMA, Putative Transmembrane Protein NMA) (FITC)
BAMBI (BMP and Activin Membrane-bound Inhibitor Homolog, Non-metastatic Gene A Protein, NMA, Putative Transmembrane Protein NMA) (FITC)
